Amgen Total Assets 2006-2020 | AMGN

Amgen total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Amgen total assets for the quarter ending March 31, 2020 were $61.669B, a 3.64% decline year-over-year.
  • Amgen total assets for 2019 were $59.707B, a 10.1% decline from 2018.
  • Amgen total assets for 2018 were $66.416B, a 16.93% decline from 2017.
  • Amgen total assets for 2017 were $79.954B, a 3% increase from 2016.
Amgen Annual Total Assets
(Millions of US $)
2019 $59,707
2018 $66,416
2017 $79,954
2016 $77,626
2015 $71,449
2014 $69,009
2013 $66,125
2012 $54,298
2011 $48,871
2010 $43,486
2009 $39,629
2008 $36,427
2007 $34,639
2006 $33,788
2005 $29,297
Amgen Quarterly Total Assets
(Millions of US $)
2020-03-31 $61,669
2019-12-31 $59,707
2019-09-30 $59,535
2019-06-30 $59,373
2019-03-31 $63,997
2018-12-31 $66,416
2018-09-30 $67,333
2018-06-30 $67,684
2018-03-31 $71,164
2017-12-31 $79,954
2017-09-30 $80,331
2017-06-30 $79,587
2017-03-31 $77,862
2016-12-31 $77,626
2016-09-30 $78,150
2016-06-30 $75,471
2016-03-31 $75,116
2015-12-31 $71,449
2015-09-30 $71,869
2015-06-30 $71,209
2015-03-31 $68,952
2014-12-31 $69,009
2014-09-30 $70,775
2014-06-30 $69,534
2014-03-31 $67,004
2013-12-31 $66,125
2013-09-30 $57,073
2013-06-30 $52,610
2013-03-31 $51,640
2012-12-31 $54,298
2012-09-30 $55,448
2012-06-30 $52,226
2012-03-31 $49,250
2011-12-31 $48,871
2011-09-30 $45,765
2011-06-30 $46,936
2011-03-31 $42,714
2010-12-31 $43,486
2010-09-30 $43,534
2010-06-30 $40,800
2010-03-31 $40,366
2009-12-31 $39,629
2009-09-30 $40,940
2009-06-30 $38,840
2009-03-31 $37,380
2008-12-31 $36,427
2008-09-30 $36,998
2008-06-30 $36,061
2008-03-31 $36,128
2007-12-31 $34,639
2007-09-30 $33,452
2007-06-30 $32,971
2007-03-31 $32,570
2006-12-31 $33,788
2006-09-30 $32,586
2006-06-30 $31,288
2006-03-31 $31,315
2005-12-31 $29,297
2005-09-30 $29,132
2005-06-30 $28,038
2005-03-31 $27,420
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $146.497B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.946B 10.86
Gilead Sciences (GILD) United States $95.734B 12.41
CSL (CSLLY) Australia $90.156B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.344B 52.49
Regeneron Pharmaceuticals (REGN) United States $68.306B 26.33
Illumina (ILMN) United States $54.427B 55.93
Biogen (BIIB) United States $45.510B 7.79
Seattle Genetics (SGEN) United States $30.180B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $25.051B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.030B 10.32
Moderna (MRNA) United States $23.242B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.796B 206.66
Genmab (GMAB) Denmark $22.796B 18.77
Incyte (INCY) United States $22.772B 0.00
Genmab (GNMSF) Denmark $21.669B 64.33
Alnylam Pharmaceuticals (ALNY) United States $18.717B 0.00
BioNTech SE (BNTX) Germany $15.920B 0.00
BeiGene (BGNE) Cayman Islands $15.246B 0.00
Exact Sciences (EXAS) United States $13.805B 0.00
Sarepta Therapeutics (SRPT) United States $13.165B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.513B 36.81
ARGENX SE-ADR (ARGX) Netherlands $11.776B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.918B 26.87
Bio-Techne Corp (TECH) United States $10.412B 68.79
QIAGEN (QGEN) Netherlands $10.319B 30.01
Immunomedics (IMMU) United States $9.541B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.643B 0.00
Guardant Health (GH) United States $8.059B 0.00
Exelixis (EXEL) United States $7.648B 26.82
SWEDISH ORP BIO (BIOVF) Sweden $6.750B 16.79
Repligen (RGEN) United States $6.597B 115.72
Ascendis Pharma (ASND) Denmark $6.573B 0.00
Adaptive Biotechnologies (ADPT) United States $5.828B 0.00
Vir Biotechnology (VIR) United States $5.743B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.544B 119.29
Novavax (NVAX) United States $5.469B 0.00
Acceleron Pharma (XLRN) United States $5.382B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.146B 0.00
Reata Pharmaceuticals (RETA) United States $5.132B 0.00
Zai Lab (ZLAB) China $5.053B 0.00
Mirati Therapeutics (MRTX) United States $5.016B 0.00
Emergent Biosolutions (EBS) United States $4.940B 32.38
MyoKardia (MYOK) United States $4.335B 0.00
Global Blood Therapeutics (GBT) United States $4.334B 0.00
Blueprint Medicines (BPMC) United States $4.279B 0.00
MorphoSys AG (MOR) Germany $4.267B 33.09
China Biologic Products (CBPO) China $4.198B 23.34
Momenta Pharmaceuticals (MNTA) United States $4.037B 0.00
Amicus Therapeutics (FOLD) United States $4.002B 0.00
Halozyme Therapeutics (HALO) United States $3.789B 0.00
NeoGenomics (NEO) United States $3.776B 275.77
Inovio Pharmaceuticals (INO) United States $3.696B 0.00
Bluebird Bio (BLUE) United States $3.561B 0.00
Arena Pharmaceuticals (ARNA) United States $3.318B 0.00
Alkermes (ALKS) Ireland $3.126B 61.53
Deciphera Pharmaceuticals (DCPH) United States $3.030B 0.00
Insmed (INSM) United States $2.813B 0.00
Fate Therapeutics (FATE) United States $2.739B 0.00
Denali Therapeutics (DNLI) United States $2.739B 0.00
Amarin (AMRN) Ireland $2.590B 0.00
PHARMA MAR SA (PHMMF) Spain $2.430B 0.00
Twist Bioscience (TWST) United States $2.242B 0.00
Principia Biopharma (PRNB) United States $2.116B 0.00
UniQure (QURE) Netherlands $2.057B 0.00
Viela Bio (VIE) United States $1.982B 0.00
Eidos Therapeutics (EIDX) United States $1.859B 0.00
Ligand Pharmaceuticals (LGND) United States $1.847B 71.91
Alector (ALEC) United States $1.841B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.840B 0.00
Editas Medicine (EDIT) United States $1.816B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.698B 0.00
Sorrento Therapeutics (SRNE) United States $1.690B 0.00
I-Mab (IMAB) China $1.683B 0.00
Intra-Cellular Therapies (ITCI) United States $1.642B 0.00
Adverum Biotechnologies (ADVM) United States $1.596B 0.00
Epizyme (EPZM) United States $1.532B 0.00
Mesoblast (MESO) Australia $1.517B 0.00
Cytokineticsorporated (CYTK) United States $1.516B 0.00
Zymeworks (ZYME) Canada $1.511B 0.00
Sangamo Therapeutics (SGMO) United States $1.506B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.485B 0.00
Mersana Therapeutics (MRSN) United States $1.444B 0.00
Revance Therapeutics (RVNC) United States $1.410B 0.00
Zealand Pharma (ZEAL) Denmark $1.410B 0.00
REGENXBIO (RGNX) United States $1.385B 0.00
Beam Therapeutics (BEAM) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NantKwest (NK) United States $1.359B 0.00
Arvinas (ARVN) United States $1.357B 0.00
Akcea Therapeutics (AKCA) United States $1.315B 0.00
NGM Biopharmaceuticals (NGM) United States $1.304B 0.00
Coherus BioSciences (CHRS) United States $1.271B 8.88
Intellia Therapeutics (NTLA) United States $1.223B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.201B 0.00
Arcus Biosciences (RCUS) United States $1.125B 0.00
Compugen (CGEN) Israel $1.085B 0.00
Athenex (ATNX) United States $1.017B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.984B 0.00
Alcobra (ARCT) United States $0.933B 0.00
VBI Vaccines (VBIV) United States $0.904B 0.00
Retrophin (RTRX) United States $0.865B 0.00
Heska (HSKA) United States $0.863B 0.00
Myriad Genetics (MYGN) United States $0.855B 44.12
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.825B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Dynavax Technologies (DVAX) United States $0.798B 0.00
Morphic Holding (MORF) United States $0.787B 0.00
Intrexon (PGEN) United States $0.780B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.746B 0.00
Vericel (VCEL) United States $0.724B 133.83
ZIOPHARM Oncology Inc (ZIOP) United States $0.722B 0.00
Castle Biosciences (CSTL) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.719B 0.00
Frequency Therapeutics (FREQ) United States $0.713B 0.00
Codexis (CDXS) United States $0.676B 0.00
Kadmon Holdings (KDMN) United States $0.674B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.636B 0.00
Agenus (AGEN) United States $0.634B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.37
Autolus Therapeutics (AUTL) United Kingdom $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
AnaptysBio (ANAB) United States $0.579B 0.00
MiMedx (MDXG) United States $0.568B 0.00
Kala Pharmaceuticals (KALA) United States $0.554B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.554B 0.00
Athersys (ATHX) United States $0.552B 0.00
Syros Pharmaceuticals (SYRS) United States $0.525B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.516B 0.00
Clovis Oncology (CLVS) United States $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.502B 16.14
NextCure (NXTC) United States $0.492B 0.00
UROGEN PHARMA (URGN) United States $0.488B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 0.00
Scholar Rock Holding (SRRK) United States $0.473B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.466B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.462B 0.00
DBV Technologies S.A (DBVT) France $0.461B 0.00
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
OSMOTICA PHARM (OSMT) United States $0.452B 0.00
Protagonist Therapeutics (PTGX) United States $0.447B 0.00
Geron (GERN) United States $0.437B 0.00
BioDelivery Sciences (BDSI) United States $0.423B 22.21
Precision BioSciences (DTIL) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.418B 0.00
Puma Biotechnology (PBYI) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.395B 0.00
Avid Bioservices (CDMO) United States $0.393B 0.00
CytomX Therapeutics (CTMX) United States $0.391B 0.00
MannKind (MNKD) United States $0.379B 0.00
Kamada (KMDA) Israel $0.377B 15.69
Albireo Pharma (ALBO) United States $0.377B 0.00
WAVE Life Sciences (WVE) Singapore $0.354B 0.00
Affimed (AFMD) Germany $0.336B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 6.53
Seres Therapeutics (MCRB) United States $0.327B 0.00
PDL BioPharma (PDLI) United States $0.320B 280.50
ChromaDex (CDXC) United States $0.314B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.306B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Prometic Life Sciences (LMNL) Canada $0.293B 0.00
Cellular Biomedicine (CBMG) United States $0.289B 0.00
Menlo Therapeutics (MNLO) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Celldex Therapeutics (CLDX) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.252B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.244B 0.00
Dyadic (DYAI) United States $0.240B 0.00
Verastem (VSTM) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.229B 0.00
Selecta Biosciences (SELB) United States $0.229B 0.00
IVERIC Bio (ISEE) United States $0.227B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.225B 0.00
Fortress Biotech (FBIO) United States $0.224B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
Pluristem Therapeutics (PSTI) Israel $0.216B 0.00
Aduro Biotech (ADRO) United States $0.216B 0.00
Liquidia Technologies (LQDA) United States $0.211B 0.00
XOMA (XOMA) United States $0.210B 0.00
Sutro Biopharma (STRO) United States $0.210B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.208B 3.13
Exicure (XCUR) United States $0.207B 0.00
Aptinyx (APTX) United States $0.205B 0.00
GENFIT S.A (GNFT) France $0.205B 0.00
Strongbridge Biopharma (SBBP) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.177B 0.00
Bellus Health (BLU) Canada $0.177B 0.00
Theratechnologies (THTX) Canada $0.176B 0.00
Trevena (TRVN) United States $0.171B 0.00
Aytu Bioscience (AYTU) United States $0.165B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
TELA Bio (TELA) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Kindred Biosciences (KIN) United States $0.153B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
Cyclerion Therapeutics (CYCN) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.132B 0.00
Lumos Pharma (LUMO) United States $0.132B 0.00
Biofrontera AG (BFRA) Germany $0.131B 0.00
Oncobiologics (OTLK) United States $0.130B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Celsion (CLSN) United States $0.114B 0.00
AIT Therapeutics (XAIR) United States $0.113B 0.00
AquaBounty Technologies (AQB) United States $0.112B 0.00
Eton Pharmaceuticals (ETON) United States $0.106B 0.00
Unum Therapeutics (UMRX) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Cardiff Oncology (CRDF) United States $0.094B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.094B 0.00
Windtree Therapeutics (WINT) United States $0.093B 0.00
Cocrystal Pharma (COCP) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.087B 0.00
Adocia (ADOCY) France $0.080B 0.00
Organovo Holdings (ONVO) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
AnPac Bio-Medical Science (ANPC) China $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Curis (CRIS) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Advaxis (ADXS) United States $0.035B 0.00
OvaScience (MLND) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
Cesca Therapeutics (THMO) United States $0.031B 0.00
Spherix (AIKI) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
IMMURON (IMRN) Australia $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
BioCardia (BCDA) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00